Session Details
[IS02☆]International Symposium on Pharmacology and Drug Therapeutics
Sat. Mar 28, 2026 1:10 PM - 3:10 PM JST
Sat. Mar 28, 2026 4:10 AM - 6:10 AM UTC
Sat. Mar 28, 2026 4:10 AM - 6:10 AM UTC
Room 04 (E301)
Organizer: Shuntaro Hara (Grad. Sch. Pharm., Showa Med. Univ.), Atsushi Matsuzawa (Grad. Sch. Pharm. Sci., Tohoku Univ.), Hisao Yamamura (Grad. Sch. Pharmaceut. Sci., Nagoya City Univ.)
[English Session]
Opening Remarks
Atsushi Matsuzawa (Grad. Sch. Pharm. Sci., Tohoku Univ., Japan)
[IS02-1]Medication safety of oral anticancer therapy
○Ulrich Jaehde1,2 (1. Dept. Clin. Pharm., Pharm. Inst, Univ. Bonn, Germany, 2. President, German Pharmaceutical Society)
[IS02-2]Clinical Utility and Prognostic Value of Direct Oral Anticoagulant (DOAC) Concentration Monitoring: From Real-World Practice to Emergency Management
○Shin-Yi Lin1,2, Ching-Hua Kuo2, Yen-Bin Liu3, Sung-Chun Tang4, Jiann-Shing Jeng4 (1. Department of Pharmacy, National Taiwan University Hospital (NTUH), Taipei, Taiwan, 2. School of Pharmacy, National Taiwan University (NTUSP), Taipei, Taiwan, 3. Cardiovascular center and division of internal medicine, NTUH, Taipei, Taiwan, 4. Department of Neurology, NTU, Taipei, Taiwan)
[IS02-3]Ion channel-targeted therapeutics for pulmonary hypertension
○Hisao Yamamura1 (1. Grad. Sch. Pharmaceut. Sci., Nagoya City Univ., Japan)
[IS02-4]Pharmacokinetics of Psilocybin/Psilocin in magic mushroom and dimethyltryptamine in Ayahuasca using PBPK modeling approach
○Manupat Lohitnavy1 (1. Center of Excellence for Environmental Health & Toxicology, Fac. Pharm. Sci., Naresuan Univ., Thailand)
[IS02-5]Studying vascular diseases using different research modalities to determine treatment options
○Noriko Daneshtalab1 (1. Sch. Pharm., Memorial Univ. Newfoundland, Canada)
